Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US74276L1052
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG009KD84H4
PRCT
Procept Biorobotics Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Medical Devices · THEMEFOLIO: $RBTX
NAME
Procept Biorobotics Corp
ISIN
US74276L1052
TICKER
PRCT
MIC
XNAS
REUTERS
PRCT.OQ
BLOOMBERG
PRCT US
Mi., 25.03.2026       PROCEPT BioRobotics
US74276L1052

Procept BioRobotics reported one set of numbers to investors -- the actual figures told a different story NEW YORK, March 25, 2026 /PRNewswire/ -- Investors in Procept BioRobotics (NASDAQ: PRCT) lost more than 15% of their investment value after the Company disclosed financial results that diverged sharply from the figures management had presente...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Do., 19.03.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ: PRCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mi., 18.03.2026       PROCEPT BioRobotics
US74276L1052

Procept BioRobotics set aggressive revenue targets while a internal pricing change was already undercutting realized salesNEW YORK, March 18, 2026 /PRNewswire/ -- Procept BioRobotics (NASDAQ: PRCT) guided investors toward $325.5 million in full-year 2025 revenue -- representing 45% growth -- then delivered $308.1 million, a $17.4 million shortfall...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mo., 16.03.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - March 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PROCEPT BioRobotics Corporation (NASDAQ: PRCT) ("PROCEPT BioRobotics Corporation") concerning potential violations of the federal securities laws.On the Q3 2025 earnings call on November 4, 2025, CFO...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ: PRCT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mi., 11.03.2026       PROCEPT BioRobotics
US74276L1052

Procept BioRobotics reported one set of numbers to investors -- the actual figures told a different storyNEW YORK, March 11, 2026 /PRNewswire/ -- Investors in Procept BioRobotics (NASDAQ: PRCT) lost more than 15% of their investment value after the Company disclosed financial results that diverged sharply from the figures management had presented....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       PROCEPT BioRobotics
US74276L1052

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LO...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       PROCEPT BioRobotics
US74276L1052

Law Offices of Howard G. Smith announces an investigation on behalf of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PROCEPT BIOROBOTICS CORPORATION (PRCT), CONTACT THE LAW OFFICES OF HOWA...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       PROCEPT BioRobotics
US74276L1052

The Law Offices of Frank R. Cruz announces an investigation of PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NASDAQ: PRCT) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PROCEPT BIOROBOTICS CORPORATION (PRCT), CLICK HERE TO INQUIRE ABOUT POT...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mo., 09.03.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PROCEPT BioRobotics Corporation ("PROCEPT BioRobotics Corporation") (NASDAQ: PRCT) concerning potential violations of the federal securities laws.On the Q3 2025 earnings call on November 4, 2025, CFO Kevin Water...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 09.03.2026       PROCEPT BioRobotics
US74276L1052

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation (“Procept” or “the Company”) (NASDAQ: PRCT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/o...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Do., 05.03.2026       PROCEPT BioRobotics
US74276L1052

NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ: PRCT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Do., 05.03.2026       PROCEPT BioRobotics
US74276L1052

Procept BioRobotics reported one set of numbers to investors -- the actual figures told a different storyNEW YORK,, March 4, 2026 /PRNewswire/ -- Investors in Procept BioRobotics (NASDAQ: PRCT) lost more than 15% of their investment value after the Company disclosed financial results that diverged sharply from the figures management had presented....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Di., 03.03.2026       PROCEPT BioRobotics
US74276L1052

New York, New York--(Newsfile Corp. - March 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PROCEPT BioRobotics Corporation ("PROCEPT BioRobotics Corporation") (NASDAQ: PRCT) concerning potential violations of the federal securities laws.On the Q3 2025 earnings call on November 4, 2025, CFO Kevin Water...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Do., 26.02.2026       PROCEPT BioRobotics
US74276L1052

MILWAUKEE, Feb. 26, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against PROCEPT BioRobotics (NASDAQ: PRCT). The investigation results from inaccurate statements PROCEPT BioRobotics may have made regarding its financial statements, business operations and prospects....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mo., 26.01.2026       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2025 after market close on Tuesday, February...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Do., 20.11.2025       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 37th Annual Piper Sandler Healthcare Conference in New York...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mi., 15.10.2025       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2025 after market close on Tuesday, November...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Do., 24.07.2025       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (“the Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that Larry L. Wood will join the Company as president and CEO effective September 2, 2025. Dr. Reza Zadno will reti...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Di., 15.07.2025       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that Aquablation therapy was assigned a Category I code effective January 1, 2026....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 24.04.2025       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2025....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Fr., 14.03.2025       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will host an in-person investor event on Friday, April 25, 2025, at the Venetian Hotel in Las Vegas...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Di., 25.02.2025       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the fourth quarter and year ended December 31, 2024....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Fr., 07.02.2025       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2024 after market close on Tuesday, February 25, 2025. T...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mi., 30.10.2024       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the pricing of an underwritten public offering of 1,923,076 shares of its com...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mo., 28.10.2024       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the commencement of an underwritten public offering of $175,000,000 of shares...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mo., 28.10.2024       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2024....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mi., 21.08.2024       PROCEPT BioRobotics
US74276L1052

Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes Designed to improve efficiency, enhance surgeon and staff experience and deliver a more accurate and consistent treatment plan for better clinical outcomes...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mo., 13.05.2024       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Leerink Partners Healthcare Crossroads Conference in A...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mi., 01.05.2024       PROCEPT BioRobotics
US74276L1052

SAN JOSE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2024....
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink
Mo., 01.05.2023       PROCEPT BioRobotics
US74276L1052

Los Angeles, California--(Newsfile Corp. - May 1, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PROCEPT BioRobotics Corporation ("Procept" or "the Company") (NASDAQ: PRCT) for violations of the securities laws.The investigation focuses on whether the C...
Zur Nachricht
PROCEPT BioRobotics
Charts & Research Termsheets Terminal
Permalink